Fourth Quarter & Full Year 2022 Financial Results and Business Update Conference Call Karim Mikhail President & CEO Tom Reilly CFO March 1, 2023 Forward Looking Statements & Disclaimer This presentation contains forward-looking statements, such as those relating to the commercial potential of VASCEPA® (VAZKEPA® in Europe), clinical and regulatory efforts and timelines, potential regulatory and pricing approvals, patent litigation, generic product launch, intellectual property, cash flow, research and develo ...